Price $101.80 |
Market Cap
14.78B
|
Sector Health Care |
Div. Growth
10.40%
|
|
P/E
21.6
|
P/B
3.16
|
P/S
1.95
|
Dividend %
1.70%
|
|
P/CF
524.5
|
P/FCF
27.0
|
Op. Cash Flow
1.1M
|
FCF
4.0
|
|
Op. Margin
15.80%
|
Net Margin
9.20%
|
ROE
15.10%
|
ROI
10.10%
|
|
ROA
6.90%
|
EPS Growth
-11.60%
|
Current Ratio
1.6
|
Debt/Equity
80.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| CRYO-CELL International, Inc. (CCEL) | $6.75 | - | - | 47.9M | Strong Buy |
| Aviragen Therapeutics Inc (AVIR) | $0.65 | - | - | 24.3M | Strong Buy |
| Misonix, Inc. (MSON) | $9.75 | - | - | 91.7M | Strong Buy |
| Dyadic International, Inc. (DYAI) | $1.44 | - | - | 42.8M | Strong Buy |
| Bioanalytical Systems, Inc. (BASI) | $1.72 | - | - | 12.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
